Dusina, Alex
 Distribuzione geografica
Continente #
NA - Nord America 1.015
AS - Asia 562
EU - Europa 514
SA - Sud America 125
Continente sconosciuto - Info sul continente non disponibili 31
AF - Africa 19
OC - Oceania 3
Totale 2.269
Nazione #
US - Stati Uniti d'America 975
SG - Singapore 289
IT - Italia 117
CN - Cina 108
BR - Brasile 105
SE - Svezia 102
FR - Francia 67
DE - Germania 62
VN - Vietnam 42
FI - Finlandia 38
GB - Regno Unito 31
IE - Irlanda 28
CA - Canada 24
IN - India 23
ID - Indonesia 20
JP - Giappone 20
HK - Hong Kong 15
PL - Polonia 14
ZA - Sudafrica 11
AR - Argentina 10
RU - Federazione Russa 10
BD - Bangladesh 9
MX - Messico 9
ES - Italia 8
AT - Austria 7
LT - Lituania 6
VE - Venezuela 6
NL - Olanda 5
PK - Pakistan 5
BE - Belgio 4
CI - Costa d'Avorio 4
UZ - Uzbekistan 4
AE - Emirati Arabi Uniti 3
AZ - Azerbaigian 3
CH - Svizzera 3
IQ - Iraq 3
IR - Iran 3
RO - Romania 3
TR - Turchia 3
AU - Australia 2
GT - Guatemala 2
MA - Marocco 2
MD - Moldavia 2
PE - Perù 2
PH - Filippine 2
PT - Portogallo 2
SA - Arabia Saudita 2
TW - Taiwan 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AL - Albania 1
BH - Bahrain 1
BY - Bielorussia 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
EU - Europa 1
JM - Giamaica 1
KE - Kenya 1
KR - Corea 1
KW - Kuwait 1
KZ - Kazakistan 1
MY - Malesia 1
NZ - Nuova Zelanda 1
PR - Porto Rico 1
SI - Slovenia 1
SV - El Salvador 1
TH - Thailandia 1
TN - Tunisia 1
TT - Trinidad e Tobago 1
UA - Ucraina 1
Totale 2.240
Città #
Singapore 166
Chandler 163
Ashburn 97
San Jose 75
Milan 47
New York 38
Beijing 37
Helsinki 33
Rome 32
Dublin 26
Los Angeles 24
Lauterbourg 20
Frankfurt am Main 19
Tokyo 19
Boston 17
Jakarta 17
San Mateo 17
Princeton 16
Hanoi 14
Ho Chi Minh City 13
Marseille 13
Montreal 13
Warsaw 13
Hong Kong 12
Munich 12
Wilmington 11
Dallas 10
São Paulo 9
Tukwila 9
Brooklyn 8
Chicago 8
Johannesburg 8
London 8
Nuremberg 8
St Louis 8
Atlanta 7
Düsseldorf 7
Orem 7
Santa Clara 7
Hefei 6
Paris 6
Pune 6
Seattle 6
The Dalles 6
Vienna 6
Denver 5
Moscow 5
Redwood City 5
Stockholm 5
Toronto 5
Abidjan 4
Brussels 4
Chennai 4
Council Bluffs 4
Haiphong 4
Manchester 4
Mexico City 4
Rosario 4
Tashkent 4
Tianjin 4
Turku 4
Andover 3
Bologna 3
Bremen 3
Cambridge 3
City of London 3
Dhaka 3
Fairfield 3
Falkenstein 3
Houston 3
Lahore 3
Memphis 3
Nanjing 3
Phoenix 3
Poplar 3
Roubaix 3
San Francisco 3
Woodbridge 3
Abu Dhabi 2
Amsterdam 2
Augusta 2
Baku 2
Bexley 2
Brescia 2
Buenos Aires 2
Buffalo 2
Calgary 2
Capannori 2
Cape Town 2
Caracas 2
Carapicuíba 2
Concord 2
Curitiba 2
Dearborn 2
Edinburgh 2
Franca 2
Genoa 2
Guangzhou 2
Guatemala City 2
Hortolândia 2
Totale 1.268
Nome #
Difference in the neurocognitive functions of WLWH and MLWH in an Italian cohort of people living with HIV 319
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 161
Are we ready for long-acting? A feasibility evaluation of long-acting cabotegravir–rilpivirine in clinical practice 153
Cohort profile: The Observational cohort for the study of DOlutegravir in Antiretroviral Combination REgimens (ODOACRE) 150
Prevalence and factors associated with HIV-1 multi-drug resistance over the past two decades in the Italian ARCA database 144
Changes in bone mineral density in HIV-positive, virologically suppressed patients switching to lamivudine/dolutegravir dual therapy: preliminary results from clinical practice 143
The University of California San Diego performance-based skills assessment: a useful tool to detect mild everyday functioning difficulties in HIV-infected patients with very good immunological condition 137
Efficacy and safety of raltegravir in switch strategies in virologically suppressed patients: long-term data from clinical practice 133
SARS-CoV-2 infection in a highly experienced person living with HIV 126
Short Communication: Comparing Lamivudine+Dolutegravir and Bictegravir/Emtricitabine/Tenofovir Alafenamide as Switch Strategies: Preliminary Results from Clinical Practice 125
Efficacy and durability of two- vs. three-drug integrase inhibitor-based regimens in virologically suppressed HIV-infected patients: Data from real-life ODOACRE cohort 119
Risk of Tumor Onset in HIV+ Patients on Two-Drug Regimens: A Cohort Study in an Italian Hospital 112
The need to continue testing for HIV, even during the coronavirus disease 2019 (COVID-19) pandemic 104
Virological outcomes with dolutegravir plus either lamivudine or two NRTIs as switch strategies: a multi-cohort study 101
Nucleoside Reverse-Transcriptase Inhibitor Resistance Mutations Predict Virological Failure in Human Immunodeficiency Virus-Positive Patients during Lamivudine plus Dolutegravir Maintenance Therapy in Clinical Practice 84
Short Communication: Efficacy and Safety of Dolutegravir plus Lamivudine as a First-Line Regimen in Clinical Practice 84
No significant changes in body fat mass in virologically suppressed, HIV-positive patients switched to lamivudine-Dolutegravir 74
Totale 2.269
Categoria #
all - tutte 10.108
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 10.108


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022113 0 1 0 7 0 2 10 22 5 5 15 46
2022/2023412 49 62 19 60 33 45 22 46 45 4 26 1
2023/2024193 13 40 0 17 8 34 15 6 5 9 27 19
2024/2025408 8 4 59 14 40 31 17 14 62 37 71 51
2025/2026877 129 13 48 109 224 49 121 39 53 60 22 10
2026/2027205 30 175 0 0 0 0 0 0 0 0 0 0
Totale 2.269